← SynDRA
ATIPAMEZOLE
SynDRA canonical compound SYN0005371 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Mechanism of action | adrenergic receptor antagonist |
|---|
| Indication | reverse sedative |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- ADRA2A
- ADRA2B
- ADRA2C
- ADRA1B
Mechanisms of action (all sources)
- ADRA2A ANTAGONIST
- ADRA2B ANTAGONIST
- ADRA2C ANTAGONIST
- adrenergic receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- AHR
- CP19A
- CP1A2
- CP2C9
- CP2CJ
- CP2D6
- CP3A4
- CP3A7
Drug classes
- Adrenergic Agents
- Adrenergic alpha-2 Receptor Antagonists
- Adrenergic alpha-Antagonists
- Adrenergic Antagonists
- Neurotransmitter Agents
Cross-references
Synonyms
- Antisedan
- Cropamezole
- Revertidine
- MPV-1248
- antisedan
- atipamezole hydrochloride
- Atipamezol
- 4-(2-ethyl-2-indanyl)imidazole.
- MPV 1248
- 4-(2-Ethyl-2-indanyl)imidazole
- Atipamezolum [Latin]
- Atipamezol [Spanish]
- UNII-03N9U5JAF6
- 03N9U5JAF6
- NCGC00182707-01
- Zeolite, type: ZSM-5
- DSSTox_CID_29061
- DSSTox_RID_83274
- DSSTox_GSID_49135
- antipamezole
- Atipamezolum
- C14H16N2
- CAS-104054-27-5
- NCGC00182707-02
- Atipamezole [USAN:INN:BAN]
- Antisedan (TN)
- MFCD00864502
- ATIPAMEZOLE [MI]
- ATIPAMEZOLE [INN]
- Atipamezole (USAN/INN)
- ATIPAMEZOLE [USAN]
- ATIPAMEZOLE [MART.]
- SCHEMBL304971
- CHEMBL353972
- DTXSID2049135
- Atipamezole, >=98% (HPLC)
- BDBM81807
- MPV1248
Look up ATIPAMEZOLE in the interactive SynDRA portal →